By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuroDerm Ltd. 

Ofakim      Israel
Phone: 925-270-0519 Fax: 925-290-1209



Company News
NeuroDerm (NDRM) Announces Patient Enrollment In Long-Term Safety Trial Of ND0612 For Parkinson’s Disease 5/9/2016 1:14:00 PM
NeuroDerm (NDRM) Announces 2016 Annual General Meeting Of Shareholders 5/5/2016 10:46:46 AM
Good News for NeuroDerm (NDRM) as the FDA Removes Import Alert of Infusion Pumps Used in ND0612 Clinical Trials 4/22/2016 7:58:01 AM
NeuroDerm (NDRM) To Host Fourth Quarter And 2015 Fiscal Year Financial Results Conference Call On March 31, 2016 3/22/2016 8:13:50 AM
NeuroDerm (NDRM) Announces Start Of Patient Enrollment In Phase II Trial Of ND0612H For Advanced Parkinson’s Disease 12/30/2015 11:53:59 AM
NeuroDerm (NDRM) CEO To Present At Upcoming Investor Conferences 11/13/2015 10:06:44 AM
NeuroDerm (NDRM) Announces Third Quarter 2015 Financial Results 11/11/2015 8:40:41 AM
NeuroDerm (NDRM) Announces Streamlined U.S. Development Plan Following FDA Feedback On ND0612H And ND0612L For The Treatment Of Parkinson's Disease 11/11/2015 8:06:43 AM
NeuroDerm (NDRM) Announces 2015 Annual General Meeting Of Shareholders 9/24/2015 9:42:38 AM
NeuroDerm (NDRM) Announces Second Quarter 2015 Financial Results And Provides Corporate Update 8/6/2015 11:13:46 AM